Zogenix shelves US IPO plans
This article was originally published in Scrip
Executive Summary
Zogenix has withdrawn its registration for a $86.3 million IPO, blaming general market conditions. The US company filed the IPO with US regulators in March to help establish a sales and marketing infrastructure as well as funding R&D activities.